Most psychiatric medications carry some risk of weight gain, but the amount varies dramatically depending on the drug class and the specific medication within it. Some can add 10 or more pounds within the first few months, while others are genuinely weight-neutral or even promote modest weight loss. Knowing which drugs fall where on that spectrum can help you have a more informed conversation with your prescriber.
Antipsychotics: The Highest-Risk Class
Antipsychotics, particularly the newer “atypical” ones, carry the greatest risk of weight gain among all psychiatric medications. Clozapine and olanzapine consistently rank at the top. In one clinical trial, 34.4% of patients on olanzapine experienced clinically significant weight gain (7% or more of their starting weight). Quetiapine and risperidone fall into a medium-to-high risk category, with risperidone associated with about 2.6 kg (roughly 5.7 pounds) of gain over 12 months in pooled trial data, and quetiapine extended-release adding about 1.2 kg (2.6 pounds) over the same period.
Not all antipsychotics are equal, though. Aripiprazole, ziprasidone, lurasidone, and haloperidol are consistently ranked as low-risk for weight gain. Lurasidone actually showed an average weight change of negative 0.4 kg at 12 months in pooled trial data, and only 5.9% of patients on it had clinically significant weight gain, compared to 34.4% on olanzapine. The difference between the best and worst options in this class is substantial.
When Weight Gain Starts and How Fast It Moves
Weight gain from antipsychotics tends to be fastest in the first few weeks of treatment. This initial surge then gradually slows, but the timeline for reaching a plateau varies widely by drug. Olanzapine typically levels off somewhere between 4 and 9 months. Clozapine can keep driving weight gain for 3.5 to nearly 4 years.
One useful early warning sign: gaining more than 5% of your body weight in the first month is the strongest predictor of significant long-term gain. If you notice your clothes fitting differently within the first few weeks of a new antipsychotic, that’s worth flagging with your prescriber sooner rather than later. The first year of treatment carries the highest risk overall.
Antidepressants: A Mixed Picture
Antidepressants are the most commonly prescribed psychiatric medications, and their weight effects range from noticeable gain to slight loss depending on the specific drug.
Tricyclic Antidepressants
Older tricyclic antidepressants like amitriptyline and nortriptyline are among the worst offenders, adding roughly 1.5 to 2 kg (3.3 to 4.4 pounds) in just 4 to 12 weeks of use. Amitriptyline in particular has been linked to continuing weight gain over 24 months, meaning it doesn’t plateau quickly. Mirtazapine, a related older antidepressant, shows a similar pattern, with about 1.74 kg of gain in the short term. These medications stimulate appetite partly by blocking histamine receptors in the brain, which increases carbohydrate cravings and overall food intake.
SSRIs and SNRIs
The SSRIs most people are prescribed today generally cause less weight gain than tricyclics, but the effects are not zero. Paroxetine is the most problematic SSRI, associated with a 21% increased risk of gaining at least 5% of body weight over a 10-year period. Escitalopram showed the highest short-term gain among SSRIs in one study, at about 0.41 kg over six months. Among the SNRIs, duloxetine added roughly 0.34 kg over six months, and venlafaxine about 0.17 kg.
These numbers look small on paper, but they represent averages. Some people gain considerably more than the average while others gain nothing. The pattern with SSRIs is also different from antipsychotics: weight gain tends to emerge after prolonged use rather than in the first weeks.
Weight-Neutral and Weight-Loss Options
Fluoxetine (Prozac) stands out as largely weight-neutral among SSRIs. In pooled trial data, it was actually associated with about 2.7 kg of weight loss compared to placebo across various dosages and treatment durations. That effect appears to work through appetite reduction and changes in eating behavior. Bupropion (Wellbutrin) is the only commonly prescribed antidepressant consistently linked to weight loss or neutrality, making it a frequent choice for people who are concerned about this side effect.
Mood Stabilizers
Lithium and valproate (Depakote), the two most widely used mood stabilizers for bipolar disorder, both cause meaningful weight gain. In one open-label study, lithium-treated patients gained an average of 8.2% of their baseline body weight, and valproate-treated patients gained 8.5%. For someone weighing 170 pounds, that translates to roughly 14 pounds. Topiramate, by contrast, was associated with a slight weight loss of 0.7% of body weight, which is one reason some prescribers consider it when weight is a concern.
Why These Medications Affect Weight
The biological explanation comes down to how these drugs interact with specific signaling systems in the brain. Many psychotropic medications block histamine receptors, which directly increases appetite and specifically drives carbohydrate cravings. They also block certain serotonin receptors involved in satiety, the feeling of fullness that normally tells you to stop eating. The medications most strongly linked to weight gain, like olanzapine and clozapine, tend to block both of these receptor types powerfully. Medications with a lighter touch on these receptors, like aripiprazole and ziprasidone, cause less appetite disruption.
This isn’t just about eating more, either. Some of these drugs appear to shift metabolism directly, affecting how the body processes fats and sugars. Patients on high-risk antipsychotics can develop elevated blood sugar, increased triglycerides, and wider waist circumference, a cluster of changes that raises cardiovascular risk over time.
Children and Adolescents Are More Vulnerable
Young people appear to be significantly more susceptible to medication-induced weight gain than adults. Medications considered weight-neutral in adults can cause substantial weight gain in children. In a comparison study of adolescents and adults both taking olanzapine for at least 24 weeks, the adolescents showed greater increases in cholesterol, LDL, and triglycerides than the adults. This heightened sensitivity makes medication selection especially important for younger patients.
Managing Weight Gain on Psychiatric Medications
The most direct strategy is choosing a lower-risk medication in the first place, when clinically appropriate. Switching from olanzapine to aripiprazole or lurasidone, for example, can make a measurable difference. But when a high-risk medication is the best option for managing a serious psychiatric condition, there are ways to offset the weight effects.
Metformin, a medication originally developed for type 2 diabetes, has the strongest evidence for counteracting antipsychotic-induced weight gain. A meta-analysis of 20 studies involving over 1,000 patients found that metformin reduced weight by an average of 3.32 kg (about 7.3 pounds) compared to placebo. Interestingly, lower doses (1,000 mg per day or less) appeared to be at least as effective as higher doses in the studies analyzed, with the low-dose group losing an average of 3.85 kg. Current guidelines suggest starting at 500 mg twice daily and increasing gradually.
Early monitoring matters. Tracking your weight weekly during the first month on a new medication gives you and your prescriber real data to work with. That first-month trajectory is the clearest signal of whether a particular drug will be a long-term problem for your weight.